Drugs / S. hominis A 9 Product
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05177328 | Jul 2022 → Aug 2023 | atopic eczema | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S. hominis A 9 Product | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05177328 ↗ |
| Modality | Other / unclassified | “new product containing commensal infection fighting bacteria” NCT05177328 ↗ |
| Route | Topical | “ShA9 applied to their right or left ventral arm” NCT05177328 ↗ |